author-photo

Rajesh Narwal

AstraZeneca

5

Papers

79

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Exposure-response (E-R) efficacy and safety (E-S) analyses of tremelimumab as monotherapy or in combination with durvalumab in patients (pts) with unresectable hepatocellular carcinoma (uHCC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Prognostic Significance of Liver Metastasis in Durvalumab-treated Lung Cancer Patients

2019 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (12)
Detecting bliss synergy in in vivo combination studies with a tumor kinetic model

2019 Pharmaceutical Statistics
Show All
- Source
- Cite
- Save
Citations (0)
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo

2019 Neurobiology of Disease
Show All
- Source
- Cite
- Save
Citations (24)
Clinical Activity, Tolerability, and Long-term Follow-up of Durvalumab in Patients With Advanced NSCLC

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (42)